CEL Celadon Pharmaceuticals Plc

    RNS Number : 4665G
  Celsis International PLC
  22 October 2008
   


 For filings with the FSA include the annex
 For filings with issuer exclude the annex 

 TR-1: Notifications of Major Interests in Shares

 1. Identity of the issuer or the underlying issuer   Celsis International
 of existing shares to which voting rights are                         plc
 attached:


 2. Reason for notification (yes/no)
                                                                               X
 An acquisition or disposal of voting rights

 An acquisition or disposal of financial instruments which may result in the
 acquisition of shares already issued to which voting rights are attached 

 An event changing the breakdown of voting rights

 Other (please specify):______________

 3. Full name of person(s) subject to notification                    HBOS plc
 obligation:
                                                                See Section 9.
 4. Full name of shareholder(s) (if different from 3):
                                                               20 October 2008
 5. Date of transaction (and date on which the
 threshold is crossed or reached if different):
                                                               21 October 2008
 6. Date on which issuer notified:
                                                         Decrease to below 10%
 7. Threshold(s) that is/are crossed or reached:


 8: Notified Details
 A: Voting rights attached to shares

 Class/type of shares    Situation previous to the triggering        Resulting situation after the triggering transaction
 If possible use ISIN    transaction
 code
                         Number of shares      Number of voting      Number of shares  Number of voting        Percentage of voting
                                               rights                                  rights                  rights

                                                                                       Direct  Indirect        Direct       Indirect
                                    2,215,538             2,215,538            56,525  56,525       1,989,271       0.258%    9.078%
 Ord 5p Shares

  
 ISIN
 GB00B0CD5F69



 B: Financial Instruments

 Resulting situation after the triggering transaction

 Type of financial instrument  Expiration date  Exercise/ conversion  No. of voting rights  Percentage of voting
                                                period/date           that may be acquired  rights
                                                                      (if the instrument
                                                                      exercised/converted)
 N/A



 Total (A+B)

 Number of voting rights  Percentage of voting rights
 2,045,796                                     9.336%



 9. Chain of controlled undertakings through which the voting rights and /or
 the financial instruments are effectively held, if applicable:
 Insight Investment Management (Global) Limited* (Indirect) - 2,043,783
 (9.327%)
  
 IIMGL manages holdings on behalf of other HBOS Group companies, and other
 third parties external to the HBOS Group), under various descretionary
 management agreements.
  
 (* - wholly owned subsidiaries of HBOS plc.)

 Proxy Voting:

 10. Name of proxy holder:                                         N/A

 11. Number of voting rights proxy holder will cease to hold:      N/A

 12. Date on which proxy holder will cease to hold voting rights:  N/A


 13. Additional information:        Notification using the total voting rights
                                                          figure of 21,912,528
 14 Contact name:                                               Kenny Melville

 15. Contact telephone number:                                   0131 243 8671


    For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUUASRWBRRUAA

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024